Our attorneys have filed a mass tort lawsuit on behalf of individuals who took the blood thinner Xarelto (rivaroxaban) and suffered severe bleeding events. Pharmaceutical organizations, including the makers of Xarelto, have a duty to ensure that their drugs are reasonably safe for use – and failure to accomplish so may be grounds for compensation. Our lawyers are functioning hard to get those hurt by the drug the compensation they are entitled to.
Even though bleeding can be a typical complication connected with anticoagulants, it has been alleged that Xarelto is much more dangerous than traditional blood thinners since no antidote exists to reverse its blood-thinning effects. This signifies that, in the occasion of an emergency, patients may possibly be at risk for irreversible bleeding issues, which includes life-threatening internal and gastrointestinal hemorrhaging.
Should you or perhaps a loved one suffered a serious bleeding event after taking Xarelto, you might have legal recourse. For a lot more info, make contact with us right now to possess your case reviewed, free of charge.
Compensation Possibilities
xarelto-compensation-photoThe plaintiffs in these lawsuits are in search of compensation from Bayer and Janssen for previous and future medical bills, lost wages, discomfort and suffering and, in circumstances of death, funeral costs. Furthermore, they are in search of punitive damages, that are normally awarded to punish the defendant and deter other organizations from acting similarly.
Why Are Lawsuits Being Filed?
Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is unsafe and defective. The plaintiffs claim that, unlike conventional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for how long does xarelto last. Simply because of this, the lawsuits claim, doctors have no effective indicates of stopping Xarelto users from bleeding within the event of an emergency. Plaintiffs within the lawsuits allege critical and fatal injuries, like cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.
In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:
The manufacturers of Xarelto marketed the drug as a superior inside the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a safe anticoagulant option.
Doctors and medical staff were not properly made aware of methods to stabilize and treat a Xarelto user within the event of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.
Xarelto is linked to critical bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing unsafe clotting.
Visit this page for much more details on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set
The attorneys within the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.